Significant difference in CD3+, CD8+, CD4+, LPL and IEL between PI-IBS patients and healthy controls have been shown providing evidence that there has been aberrant mucosal immune response to the luminal environment in PI-IBS [37]. This evidence concerns the gene CD8A and irritable bowel syndrome.